DISC MEDICINE INC (IRON) Stock Overview
NASDAQ:IRON - US2546041011 - Common Stock
IRON Key Statistics, Chart & Performance
The current stock price of IRON is 60.35 USD. In the past month the price decreased by -0.43%. In the past year, price increased by 22.14%.
IRON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.89 | 372.00B | ||
| AMGN | AMGEN INC | 13.47 | 157.94B | ||
| GILD | GILEAD SCIENCES INC | 14.83 | 142.77B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.32 | 101.47B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.92 | 63.65B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 71.2 | 40.39B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.78 | 33.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.66B | ||
| INSM | INSMED INC | N/A | 25.02B | ||
| NTRA | NATERA INC | N/A | 22.61B | ||
| BIIB | BIOGEN INC | 8.7 | 20.41B |
Related stock screener links
About IRON
Company Profile
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company is headquartered in Watertown, Massachusetts and currently employs 84 full-time employees. The company went IPO on 2020-08-12. The firm's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. The company is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.
Company Info
DISC MEDICINE INC
321 Arsenal Street, Suite 101
Watertown MASSACHUSETTS US
Employees: 84
Phone: 16176749274
DISC MEDICINE INC / IRON FAQ
What is the stock price of DISC MEDICINE INC today?
The current stock price of IRON is 60.35 USD. The price increased by 1% in the last trading session.
What is the ticker symbol for DISC MEDICINE INC stock?
The exchange symbol of DISC MEDICINE INC is IRON and it is listed on the Nasdaq exchange.
On which exchange is IRON stock listed?
IRON stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DISC MEDICINE INC stock?
19 analysts have analysed IRON and the average price target is 99.2 USD. This implies a price increase of 64.37% is expected in the next year compared to the current price of 60.35. Check the DISC MEDICINE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DISC MEDICINE INC worth?
DISC MEDICINE INC (IRON) has a market capitalization of 2.09B USD. This makes IRON a Mid Cap stock.
How many employees does DISC MEDICINE INC have?
DISC MEDICINE INC (IRON) currently has 84 employees.
What are the support and resistance levels for DISC MEDICINE INC (IRON) stock?
DISC MEDICINE INC (IRON) has a support level at 60.29 and a resistance level at 60.52. Check the full technical report for a detailed analysis of IRON support and resistance levels.
Should I buy DISC MEDICINE INC (IRON) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IRON, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IRON, evaluating the profitability, health, valuation and growth aspects
- DISC MEDICINE INC (IRON) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DISC MEDICINE INC (IRON) Sales and EPS estimates to see what analysts future expectations are.
- DISC MEDICINE INC (IRON) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DISC MEDICINE INC (IRON) Insider and Institutional Ownership to learn about the owners and their transactions.
- DISC MEDICINE INC (IRON) Stock Chart to make your own analysis
- DISC MEDICINE INC (IRON) Latest news and press-releases to stay up to date.
Does DISC MEDICINE INC (IRON) stock pay dividends?
IRON does not pay a dividend.
When does DISC MEDICINE INC (IRON) report earnings?
DISC MEDICINE INC (IRON) will report earnings on 2025-11-10, before the market open.
What is the Price/Earnings (PE) ratio of DISC MEDICINE INC (IRON)?
DISC MEDICINE INC (IRON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.47).
What is the Short Interest ratio of DISC MEDICINE INC (IRON) stock?
The outstanding short interest for DISC MEDICINE INC (IRON) is 8.3% of its float. Check the ownership tab for more information on the IRON short interest.
IRON Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to IRON. When comparing the yearly performance of all stocks, IRON is one of the better performing stocks in the market, outperforming 83.59% of all stocks.
IRON Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IRON. The financial health of IRON is average, but there are quite some concerns on its profitability.
IRON Financial Highlights
Over the last trailing twelve months IRON reported a non-GAAP Earnings per Share(EPS) of -4.47. The EPS decreased by -24.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.42% | ||
| ROE | -17.64% | ||
| Debt/Equity | 0.04 |
IRON Forecast & Estimates
19 analysts have analysed IRON and the average price target is 99.2 USD. This implies a price increase of 64.37% is expected in the next year compared to the current price of 60.35.